Rebimastat (BMS-275291)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 19:56, 20 June 2023 by Jwarner (talk | contribs) (Jwarner moved page BMS-275291 to Rebimastat (BMS-275291))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

From the NCI Drug Dictionary: A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs).

Retrieved from "https://hemonc.org/w/index.php?title=Rebimastat_(BMS-275291)&oldid=74116"